AxoGen AXGN
$55.75 −$0.60 (-1.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.10 +0.63%
Open$55.71
Prev close$56.35
Day range$55.03 – $56.91
Volume876.1K
Market cap$3.33B
P/E (TTM)–
Dividend yield–
AXGN Stock News
Headlines matching AxoGen or the AXGN ticker, most recent first.
- Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
- Truist Financial Maintains AxoGen(AXGN.US) With Buy Rating
- Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55
- Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $53 Positive
- Truist Financial Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $60
- Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50 Positive
- A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55
- CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50
- A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $48 to $55
- A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $50 to $50
- Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50
- CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $45 Positive
- Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50 Positive
- CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40
- Mizuho Securities Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40
No comments yet — be the first to weigh in on AXGN.
Sign in to join the discussion.